Skip to main content
. 2020 Dec 15;16(12):2029–2035. doi: 10.5664/jcsm.8756

Table 1.

Comparisons of demographics, clinical variables and sleep characteristics in ASD chronic insomnia patients with and without RLS.

Variable RLS Negative RLS Positive P-value
Total n (%) 62 (60.2) 41 (39.8)
Sex, male 46 (74.2) 36 (87.8) .09
Age, in yearsa 8.2 ± 4.3 7.7 ± 3.6 .58
Clinical sleep disturbance
 Onset problem 16 (25.8) 17 (41.4) .095
 Maintenance problem 15 (24.2) 7 (17.0) .388
 Both 31 (50.0) 17 (41.4) .395
Nocturnal motor complaint**
 Presence of a motor complaint 35 (56.4) 41 (100) **
 Presence of >2 motor complaintsb 1 (1.6) 6 (14.6) **
 Absence of motor symptoms 27 (43.5) 0 **
 Restless sleeper 18 (29.0) 14 (34.1) **
 Leg complaint (any) 2 (3.2) 22 (53.6) **
 Leg kicking 2 (3.2) 9 (21.9) **
 Nocturnal pacing 0 2 (4.8) **
 Nocturnal walking 1 (1.6) 1 (2.4) **
 Body rocking 1 (1.6) 5 (12.2) **
 Head banging 2 (3.2) 1 (2.4) **
 Need to rub legs/feet 0 1 (2.4) **
Comorbid ADHD 11 (17.7) 6 (14.6) .4
Family history of RLS 6 (9.6) 7 (17.0) .34
Medication exposure
 SSRI 5 (8.06) 6 (14.6) .304
 Atypical Antipsychotic 9 (14.5) 4 (9.75) .476
 Antihistamine 4 (6.45) 3 (7.31) 1.0
Mean Baseline Ferritina 56.7 ± 17.59 29 ± 18.62 <.0001*
PSG Data Available 16 (25.8) 22 (53.6)
PLMS >5 on PSG 0 17 (77)
Mean PLMS on PSGa 0.06 ± 0.174 8.12 ± 6.59 <.0001*

Although not shown in this table, ferritins significantly improved in the RLS group after treatment; paired t test: mean difference 23 ± 21.0, P < .0001.

*

P value < .05 level of significance. **Motor symptoms used by clinician to establish the diagnosis of RLS were excluded from statistical analysis. aContinuous variable expressed as mean ± standard deviation. bExcludes caregiver report of “restless sleep.” ADHD = attention deficit hyperactivity disorder, n = number of study patients, % = percentage, PLMS = periodic limb movements of sleep, PSG = polysomnogram, RLS = restless legs syndrome, SSRI = selective serotonin reuptake inhibitor.